These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8676342)
1. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. Soler F; Poujade C; Evers M; Carry JC; Hénin Y; Bousseau A; Huet T; Pauwels R; De Clercq E; Mayaux JF; Le Pecq JB; Dereu N J Med Chem; 1996 Mar; 39(5):1069-83. PubMed ID: 8676342 [TBL] [Abstract][Full Text] [Related]
2. Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action. Evers M; Poujade C; Soler F; Ribeill Y; James C; Lelièvre Y; Gueguen JC; Reisdorf D; Morize I; Pauwels R; De Clercq E; Hénin Y; Bousseau A; Mayaux JF; Le Pecq JB; Dereu N J Med Chem; 1996 Mar; 39(5):1056-68. PubMed ID: 8676341 [TBL] [Abstract][Full Text] [Related]
3. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. Kashiwada Y; Hashimoto F; Cosentino LM; Chen CH; Garrett PE; Lee KH J Med Chem; 1996 Mar; 39(5):1016-7. PubMed ID: 8676334 [No Abstract] [Full Text] [Related]
4. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. Dang Z; Lai W; Qian K; Ho P; Lee KH; Chen CH; Huang L J Med Chem; 2009 Dec; 52(23):7887-91. PubMed ID: 19526990 [TBL] [Abstract][Full Text] [Related]
5. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Mayaux JF; Bousseau A; Pauwels R; Huet T; Hénin Y; Dereu N; Evers M; Soler F; Poujade C; De Clercq E Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3564-8. PubMed ID: 8170948 [TBL] [Abstract][Full Text] [Related]
6. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid. Sun IC; Chen CH; Kashiwada Y; Wu JH; Wang HK; Lee KH J Med Chem; 2002 Sep; 45(19):4271-5. PubMed ID: 12213068 [TBL] [Abstract][Full Text] [Related]
7. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1. Lai W; Huang L; Ho P; Li Z; Montefiori D; Chen CH Antimicrob Agents Chemother; 2008 Jan; 52(1):128-36. PubMed ID: 17954689 [TBL] [Abstract][Full Text] [Related]
8. Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action. Huang L; Yuan X; Aiken C; Chen CH Antimicrob Agents Chemother; 2004 Feb; 48(2):663-5. PubMed ID: 14742233 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antiviral activity of hydrazides and substituted benzalhydrazides of betulinic acid and its derivatives]. Flekhter OB; Boreko EI; Nigmatullina LR; Pavlova NI; Nikolaeva SN; Savinova OV; Eremin VF; Baltina LA; Galin FZ; Tolstikov GA Bioorg Khim; 2003; 29(3):326-32. PubMed ID: 12845810 [TBL] [Abstract][Full Text] [Related]
10. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. Holz-Smith SL; Sun IC; Jin L; Matthews TJ; Lee KH; Chen CH Antimicrob Agents Chemother; 2001 Jan; 45(1):60-6. PubMed ID: 11120945 [TBL] [Abstract][Full Text] [Related]
11. Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase. Visalli RJ; Ziobrowski H; Badri KR; He JJ; Zhang X; Arumugam SR; Zhao H Bioorg Med Chem Lett; 2015 Aug; 25(16):3168-71. PubMed ID: 26112446 [TBL] [Abstract][Full Text] [Related]
12. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Kanamoto T; Kashiwada Y; Kanbara K; Gotoh K; Yoshimori M; Goto T; Sano K; Nakashima H Antimicrob Agents Chemother; 2001 Apr; 45(4):1225-30. PubMed ID: 11257038 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444 [TBL] [Abstract][Full Text] [Related]
15. Structure and Anti-HIV Activity of Betulinic Acid Analogues. Huang QX; Chen HF; Luo XR; Zhang YX; Yao X; Zheng X Curr Med Sci; 2018 Jun; 38(3):387-397. PubMed ID: 30074203 [TBL] [Abstract][Full Text] [Related]
16. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking. Lan P; Chen WN; Huang ZJ; Sun PH; Chen WM J Mol Model; 2011 Jul; 17(7):1643-59. PubMed ID: 20978914 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants. Dang Z; Qian K; Ho P; Zhu L; Lee KH; Huang L; Chen CH Bioorg Med Chem Lett; 2012 Aug; 22(16):5190-4. PubMed ID: 22818973 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Huang L; Ho P; Lee KH; Chen CH Bioorg Med Chem; 2006 Apr; 14(7):2279-89. PubMed ID: 16314103 [TBL] [Abstract][Full Text] [Related]